Chapter 19. Dementia-Related Disorders Medication Therapy Management Data Set
Which of the following is the most important component of an initial MTM interview with a patient or caregiver regarding dementia?
a. Dedicate sufficient time for the visit
b. After the interview, ask the patient or caregiver, "Do you have any questions?"
c. Avoid discussing any sensitive issues such as inevitable decline, psychiatric complications (eg, depression, anxiety), or family support
d. Do not focus on their educational or health literacy status, since the MTM form is going to the primary physician
When performing a patient assessment it is crucial to:
a. Refer the patient to an assisted-living facility, despite his or her level of functioning
b. Review the current medication profile and ask about over-the-counter products and neutraceuticals
c. Avoid using any scales or inventories, since their use is limited in patients with dementia
d. Stay emotionless and focus on obtaining a detailed patient history
Which of the following is considered a therapeutic failure that may warrant a change in cognitive medications (eg, donepezil, galantamine)?
a. No change from baseline in the MMSE scores
b. A decrease from baseline in the MMSE by 1 to 2 points in a year
c. A decrease from baseline in the MMSE by 5 points in a year
d. Loose stools during the first 3 days of cholinesterase inhibitor therapy
Which of the following statements demonstrates proper use of living room language?
a. You have Alzheimer's disease. This is a neurocognitive disorder that will cause a deterioration of your cognitive abilities over time.
b. You have Alzheimer's disease. This is a disease that affects your memory and the ability to take care of yourself over time.
c. You have Alzheimer's disease. Pharmacologic treatment options include cholinesterase inhibitors and N-methyl-D-aspartate inhibitors, which work by regulating your neurotransmitters.
d. You have Alzheimer's disease. This is a cognitive disease, which can cause psychiatric conditions such as anhedonia, alogia, psychosis, and overall deterioration of your activities of daily life.
GR is a 75-year-old male who was recently diagnosed with Alzheimer's disease. His ...